AK119, A CD73 TARGETING ANTIBODY WITH DUAL MECHANISM OF ACTION

被引：1

作者：

Huang, Zhaoliang ^{[1
]}

Pang, Xinghua ^{[2
]}

Zhong, Tingting ^{[2
]}

Jin, Chunshan ^{[2
]}

Chen, Na ^{[2
]}

He, Xinrong ^{[2
]}

Xia, Dennis ^{[2
]}

Jin, Xiaoping ^{[3
]}

Wang, Zhongmin ^{[2
]}

Xia, Xu ^{[2
]}

Li, Baiyong ^{[2
]}

机构：

[1] Akeso Bliopharma Inc, Zhongshan, Peoples R China

[2] Akeso Biopharma Inc, Zhongshan, Peoples R China

[3] Akeso Biopharma Inc, Potomac, MD USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.750

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

750

引用

页码：A783 / A784

页数：2

共 50 条

[31] Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
Piovesan, Dana
Tan, Joanne B. L.
Becker, Annette
Banuelos, Jesus
Narasappa, Nell
DiRenzo, Daniel
Zhang, Kristen
Chen, Ada
Ginn, Elaine
Udyavar, Akshata R.
Yin, Fangfang
Paprcka, Susan L.
Purandare, Bhamini
Park, Timothy W.
Kimura, Nikki
Kalisiak, Jaroslaw
Young, Stephen W.
Powers, Jay P.
Schindler, Uli
Sivick, Kelsey E.
Walters, Matthew J.
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (06) : 948 - 959
[32] Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor
Wang, Yuan
Wang, Chuanhao
Zhu, Yazhao
Zhang, Yanming
Chen, Baobao
Wu, Yuelin
Yao, Jianzhong
Miao, Zhenyuan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 34
[33] Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
Terp, Mikkel G.
Olesen, Kristina A.
Arnspang, Eva C.
Lund, Rikke R.
Lagerholm, B. Christoffer
Ditzel, Henrik J.
Leth-Larsen, Rikke
JOURNAL OF IMMUNOLOGY, 2013, 191 (08): : 4165 - 4173
[34] Adenosine and AMP gene expression profiles predict response to adenosine pathway therapies and indicate a need for dual blockade of CD73 and A2AR with CD73 inhibitors
Willingham, Stephen
Hotson, Drew
Hsieh, Jessica
Munneke, Brian
Kwei, Long
Buggy, Joseph
Miller, Richard
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[35] CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages
Samudra, Anushka N.
Dwyer, Karen M.
Selan, Carly
Freddi, Susanna
Murray-Segal, Lisa
Nikpour, Mandana
Hickey, Michael J.
Peter, Karlheinz
Robson, Simon C.
Sashindranath, Maithili
Cowan, Peter J.
Nandurkar, Harshal H.
JOURNAL OF AUTOIMMUNITY, 2018, 88 : 131 - 138
[36] CD39 and CD73 Activity Are Protective in a Mouse Model of Antiphospholipid Antibody-Induced Miscarriage
Nandurkar, Harshal
Samudra, Anushka
Dwyer, Karen
Selan, Carly
Freddi, Sussana
Nikpour, Mandana
Hickey, Michael
Peter, Karlheinz
Robson, Simon
Sashindranath, Maithili
Cowan, Peter
BLOOD, 2017, 130
[37] A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
Kellner, Markus
von Neubeck, Bettina
Czogalla, Bastian
Feederle, Regina
Vick, Binje
Jeremias, Irmela
Zeidler, Reinhard
BIOMEDICINES, 2022, 10 (04)
[38] Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
Yun-Shan Lin
Shu-Fen Chiang
Chia-Yi Chen
Wei-Ze Hong
Tsung-Wei Chen
William Tzu-Liang Chen
Tao-Wei Ke
Pei-Chen Yang
Ji-An Liang
An‑Cheng Shiau
K. S. Clifford Chao
Kevin Chih-Yang Huang
Cancer Immunology, Immunotherapy, 2023, 72 : 2283 - 2297
[39] Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer
Allard, Bertrand
Turcotte, Martin
Stagg, John
EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (08) : 863 - 881
[40] Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
Lin, Yun-Shan
Chiang, Shu-Fen
Chen, Chia-Yi
Hong, Wei-Ze
Chen, Tsung-Wei
Chen, William Tzu-Liang
Ke, Tao-Wei
Yang, Pei-Chen
Liang, Ji-An
Shiau, An-Cheng
Chao, K. S. Clifford
Huang, Kevin Chih-Yang
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2283 - 2297

← 1 2 3 4 5 →